CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 158 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $19,519,742 | +141.4% | 508,062 | +45.4% | 0.00% | +100.0% |
Q1 2023 | $8,086,433 | +45.5% | 349,306 | +64.6% | 0.00% | +100.0% |
Q4 2022 | $5,559,011 | -29.8% | 212,176 | -47.3% | 0.00% | -50.0% |
Q3 2022 | $7,915,000 | +93.6% | 402,590 | +72.2% | 0.00% | +100.0% |
Q2 2022 | $4,088,000 | +6.4% | 233,729 | -0.4% | 0.00% | 0.0% |
Q1 2022 | $3,841,000 | +7.9% | 234,738 | +7.6% | 0.00% | 0.0% |
Q4 2021 | $3,560,000 | +43.1% | 218,226 | +11.9% | 0.00% | 0.0% |
Q3 2021 | $2,487,000 | +14.7% | 194,937 | +27.0% | 0.00% | – |
Q2 2021 | $2,168,000 | +637.4% | 153,530 | +712.1% | 0.00% | – |
Q1 2021 | $294,000 | -10.9% | 18,905 | -9.1% | 0.00% | – |
Q4 2020 | $330,000 | – | 20,798 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parallel Advisors, LLC | 5 | $0 | 0.00% |